TLPH vs UPC

Talphera, Inc. vs Universe Pharmaceuticals Inc — Valuation Comparison 2026

TLPH

Drug Manufacturers - Specialty & Generic
Talphera, Inc.
Quality
5.6
out of 10
Value Trap
51
WARN
Price
$0.82
Last close
Models
9/13
Active
VS

UPC

Drug Manufacturers - Specialty & Generic
Universe Pharmaceuticals Inc
Quality
1.5
out of 10
Value Trap
15
SAFE
Price
$2.85
Last close
Models
6/13
Active

Model-by-Model Comparison

ModelType TLPH Fair ValueTLPH Upside UPC Fair ValueUPC Upside
Bayesian DCF Intrinsic $0.26 -68.7% $0.56 -80.2%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $0.68 -17.6%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $0.07 -90.9% $9.06 +235.7%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for TLPH vs UPC — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

TLPH vs UPC — Which Stock Is More Undervalued?

TLPH scores higher with a 5.6/10 quality rating vs UPC's 1.5/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Talphera, Inc. (TLPH) and Universe Pharmaceuticals Inc (UPC) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

TLPH currently trades at $0.82 with a QOC of 5.6/10, while UPC trades at $2.85 with a QOC of 1.5/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).